Kim, Hee Seung
Park, Sang-Yoon
Park, Chan-Yong
Kim, Young Tae
Kim, Beob-Jong
Song, Yong Jung
Kim, Byoung-Gie
Kim, Yong Beom
Cho, Chi-Heum
Kim, Jong-Hyeok
Song, Yong Sang
Funding for this research was provided by:
Chong Kun Dang Pharmaceutical.
Article History
Received: 2 February 2020
Revised: 20 August 2020
Accepted: 4 September 2020
First Online: 30 September 2020
Ethics approval and consent to participate
: The Institutional Review Board (IRB) at Seoul National University Hospital (No. H-1011-035-339), National Cancer Center (No. NCCCTS-10-519), Gil Medical Center (No. GIRBA2426), Severance Hospital (No. 4-2010-0666), Korea Cancer Center Hospital (No. K-1102-001-001), Pusan National University Yangsan Hospital (No. 02-2013-014), Samsung Medical Center (No. SMC 2010-12-005), Seoul National University Bundang Hospital (No. B-1103-123-002), Dongsan Medical Center (No. 10-165) and Asan Medical Center (No. 2010-0813) approved the protocol version 1.0 for the current study. We enroled all patients in this study after we obtain their written consents.
: A central manager had independent access to all data and materials. The central manager managed the database by sending queries about errors entered from each institution and having principal investigators or clinical research nurses make corrections to the entered data.
: S.-Y.P., C.-Y.P., Y.T.K., B.-J.K., Y.J.S., B.-G.K., Y.B.K., C.-H.C., J.H.K. and Y.S.S. received research funding from Chong Kun Dang Pharmaceutical, whereas HSK declares no conflict of interest.
: This work was supported by Chong Kun Dang Pharmaceutical.